Atossa Therapeutics Inc (NASDAQ: ATOS) closed the day trading at $1.03 up 5.09% from the previous closing price of $0.98. In other words, the price has increased by $+0.0499 from its previous closing price. On the day, 503048 shares were traded.
Ratios:
For a better understanding of ATOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.35 and its Current Ratio is at 28.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 when WEAVER GREGORY L sold 50,000 shares for $0.65 per share. The transaction valued at 32,500 led to the insider holds 55 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 129.06M and an Enterprise Value of 35.03M.
Stock Price History:
Over the past 52 weeks, ATOS has reached a high of $1.39, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 0.8806, while the 200-Day Moving Average is calculated to be 0.8640.
Shares Statistics:
Over the past 3-months, ATOS traded about 425.17K shares per day on average, while over the past 10 days, ATOS traded about 498.23k shares per day. A total of 126.62M shares are outstanding, with a floating share count of 125.28M. Insiders hold about 0.02% of the company’s shares, while institutions hold 19.14% stake in the company. Shares short for ATOS as of Jan 31, 2024 were 6.84M with a Short Ratio of 16.08, compared to 6.36M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.46% and a Short% of Float of 5.46%.
Earnings Estimates
Current recommendations for the stock of the company come from 3 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.06, while EPS last year was -$0.06. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.23 and -$0.24 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.26, with 3 analysts recommending between -$0.25 and -$0.26.
